Encephalitis resident survival guide: Difference between revisions
MoisesRomo (talk | contribs) No edit summary |
MoisesRomo (talk | contribs) No edit summary |
||
Line 43: | Line 43: | ||
==Diagnosis== | ==Diagnosis== | ||
Shown below is an algorithm summarizing the diagnosis of encephalitis according to the | Shown below is an algorithm summarizing the diagnosis of encephalitis according to the International Encephalitis Consortium guidelines: | ||
<br /> | <br /> | ||
{{Family tree/start}} | {{Family tree/start}} | ||
{{Family tree | | | | A01 | | | |A01= Patient | {{Family tree | | | | | | | | | | | | | | | | | | | | A01 | | | |A01= Patient suspicious for encephalitis}} | ||
{{Family tree | | | | |!| | | | | }} | {{Family tree | | | | | | | | | | | | | | | | | | | | |!| | | | | }} | ||
{{Family tree | | | | B01 | | | |B01= | {{Family tree | | | | | | | | | | | | | | | | | | | | B01 | | | | | |B01= PERFORM:<br>• CSF analysis (at least 20 ml): Opening pressure, WBC count with differential, RBC count, protein, glucose, Gram stain and bacterial culture<br>• Routine blood testing<br>• Blood cultures<br>• HSV-1/2 PCR<br>• VZV PCR<br>• Enterovirus PCR<br>• Cryptococcal antigen and/or India Ink staining<br>• Oligoclonal bands and IgG index<br>• VDRL<br>• HIV serology<br>• Hold acute serum and collect convalescent serum 10–14 d later for paired antibody testing<br>• Neuroimaging (MRI preferred to CT, if available)<br>• Chest imaging (Chest x-ray and/or CT)<br>• EEG}} | ||
Gram stain and bacterial culture<br>• Routine blood cultures<br>• HSV-1/2 PCR<br>• VZV PCR<br>• Enterovirus PCR<br>• Cryptococcal antigen and/or India Ink staining<br>• Oligoclonal bands and IgG index<br>• VDRL<br>• HIV serology<br>• Hold acute serum and collect convalescent serum 10–14 d later for paired antibody testing<br>• Neuroimaging (MRI preferred to CT, if available)<br>• Chest imaging (Chest x-ray and/or CT)<br>• EEG}} | {{Family tree | | | | | | | | | | | | | | | | | | | | |!| | | | | }} | ||
{{Family tree | | | | | | | | | | | | | | | | | | | | A01 | | | |A01= Evaluate further testing if additional risk factors are present}} | |||
{{Family tree | |,|-|-|-|-|-|-|v|-|-|-|-|-|-|v|-|-|-|-|^|-|-|-|-|v|-|-|-|-|-|-|v|-|-|-|-|-|-|.| | }} | |||
{{Family tree | B01 | | | | | B02 | | | | | B03 | | | | | | | | B04 | | | | | B05 | | | | | B06 | B01= Host factors| B02= Geographic factors| B03= Season and exposure| B04= Specific signs and symptoms| B05= laboratory features| B06= Neuroimaging features}} | |||
{{Family tree | |!| | | | | | |!| | | | | | |!| | | | | | | | | |!| | | | | | |!| | | | | | |!| }} | |||
{{Family tree | |`|-| E01 | | |)|-| E02 | | |)|-| E03 | | | | | |)|-| E04 | | |)|-| E05 | | |)|-| E06 |E01=Immunocompromised:<br>• CMV PCR<br>• HHV6/7 PCR<br>• HIV PCR (CSF)<br>• Toxoplasma gondii serology and/or PCR<br>• MTB testing<br>• Fungal testing<br>• WNV testing |E02=Africa:<br>• Malaria (blood smear)<br>• Trypanosomiasias (blood/CSF smear<br>• Serology from serum and CSF)<br>• Dengue testing |E03=Summer/Fall:<br>• Arbovirusd and tick-borne disease testing |E04=Psychotic features or movement disorder:<br>• Anti-NMDAR antibody (serum, CSF)<br>• Rabies testing<br>• Screen for malignancy<br>• Creutzfeld-Jakobs disease |E05= |E06= }} | |||
{{Family tree | | | | | | | | |!| | | | | | |!| | | | | | | | | |!| | | | | | |!| | | | | | |!| | }} | |||
{{Family tree | | | | | | | | |)|-| E02 | | |)|-| E03 | | | | | |)|-| E04 | | |)|-| E05 | | |)|-| E06 | |E02=Asia:<br>• Japanese encephalitis virus testing<br>• Dengue testing<br>• Malaria (blood smear)<br>• Nipah virus testing|E03=Cat exposure (particularly if with seizures, paucicellular CSF):<br>• Bartonella antibody (serum), ophthalmologic evaluation |E04=Prominent limbic symptoms:<br>• Autoimmune limbic encephalitis testing<br>• HHV6/7 PCR (CSF)<br>• Screen for malignancy |E05= |E06= }} | |||
{{Family tree | | | | | | | | |!| | | | | | |!| | | | | | | | | |!| | | | | | |!| | | | | | |!| | }} | |||
{{Family tree | | | | | | | | |)|-| E01 | | |)|-| E02 | | | | | |)|-| E03 | | |)|-| E04 | | |)|-| E05 | | |E01=Australia:<br>• Murray Valley encephalitis virus testingd<br>• Kunjin virus testingd<br>• Australian Bat Lyssavirus (ABLV) testing |E02=Tick exposure:<br>• Tick borne disease testing |E03=Rapid decompensation (particularly with animal bite history or prior travel to rabies-endemic areas):<br>• Rabies testing |E04= |E05= }} | |||
{{Family tree | | | | | | | | |!| | | | | | |!| | | | | | | | | |!| | | | | | |!| | | | | | | }} | |||
{{Family tree | | | | | | | | |)|-| E02 | | |)|-| E03 | | | | | |)|-| E04 | | |)|-| E05 | | |)|-| E06 | |E02=Europe:<br>• Tick-borne encephalitis virus (serology) |E03=Animal bite/bat exposure:<br>• Rabies testing |E04=Respiratory symptoms:<br>• Mycoplasma pneumoniae serology and throat PCR (if either positive, then do CSF PCR)<br>• Respiratory virus testing |E05= |E06= }} | |||
{{Family tree | | | | | | | | |!| | | | | | |!| | | | | | | | | |!| | | | | | |!| | | | | | | }} | |||
{{Family tree | | | | | | | | |)|-| E02 | | |)|-| E03 | | | | | |)|-| E04 | | |)|-| E05 | | |)|-| E06 | |E02=Southern Europe:<br>• WNV testing<br>• Toscana virus testing |E03=Swimming or diving in warm freshwater or nasal/sinus irrigation:<br>• Naegleria fowleri (CSF wet mount and PCR) |E04=Acute flaccid paralysis:<br>• Arbovirus testingd<br>• Rabies testing |E05= |E06= }} | |||
{{Family tree | | | | | | | | |!| | | | | | |!| | | | | | | | | |!| | | | | | |!| | | | | | | }} | |||
{{Family tree | | | | | | | | |)|-| E02 | | |)|-| E03 | | | | | |)|-| E04 | | |)|-| E05 | | |)|-| E06 | |E02=Central and South America:<br>• Dengue testingd<br>• Malaria (blood smear)<br>• WNV<br>• Venezuelan equine encephalitis testing |E03=Parkinsonism:<br>• Arbovirus testingd<br>• Toxoplasma serology |E04= |E05= |E06= }} | |||
{{Family tree | | | | | | | | |!| | | | | | |!| | | | | | | | | |!| | | | | | |!| | | | | | | }} | |||
{{Family tree | | | | | | | | |)|-| E02 | | |)|-| E03 | | | | | |)|-| E04 | | |)|-| E05 | | |)|-| E06 | |E02=North America:<br>• Geographically appropriate arboviral testing (eg, WNV, Powassan, LaCrosse, Eastern Equine Encephalitis virusesd, Lyme(serum ELISA and Western blot) |E03=Nonhealing skin lesions:<br>• Balamuthia mandrillaris<br>• Acanthamoeba testing |E04= |E05= |E06= }} | |||
{{Family tree | | | | | | | | |!| | | | | | |!| | | | | | | | | |!| | | | | | |!| | | | | | | }} | |||
{{Family tree | | | | | | | | |)|-| E02 | | |)|-| E03 | | | | | |)|-| E04 | | |)|-| E05 | | |)|-| E06 | |E02= |E03= |E04= |E05= |E06= }} | |||
{{Family tree/end}} | {{Family tree/end}} | ||
Line 59: | Line 78: | ||
| colspan="1" rowspan="1" |'''Major Criterion (required):''' | | colspan="1" rowspan="1" |'''Major Criterion (required):''' | ||
|- | |- | ||
| colspan="1" rowspan="1" |Patients presenting to medical attention with altered mental status (defined as decreased or altered level of consciousness, lethargy | | colspan="1" rowspan="1" |Patients presenting to medical attention with altered mental status (defined as decreased or altered level of consciousness, lethargy, or personality change) lasting ≥24 h with no alternative cause identified. | ||
|- | |- | ||
| colspan="1" rowspan="1" |'''Minor Criteria (2 required for possible encephalitis; ≥3 required for probable or confirmeda encephalitis):''' | | colspan="1" rowspan="1" |'''Minor Criteria (2 required for possible encephalitis; ≥3 required for probable or confirmeda encephalitis):''' | ||
Line 71: | Line 90: | ||
| colspan="1" rowspan="1" |CSF WBC count ≥5/cubic mmd | | colspan="1" rowspan="1" |CSF WBC count ≥5/cubic mmd | ||
|- | |- | ||
| colspan="1" rowspan="1" |Abnormality of brain parenchyma on neuroimaging suggestive of encephalitis that is either new from prior studies or appears acute in | | colspan="1" rowspan="1" |Abnormality of brain parenchyma on neuroimaging suggestive of encephalitis that is either new from prior studies or appears acute in onset | ||
|- | |- | ||
| colspan="1" rowspan="1" |Abnormality on electroencephalography that is consistent with encephalitis and not attributable to another cause.f | | colspan="1" rowspan="1" |Abnormality on electroencephalography that is consistent with encephalitis and not attributable to another cause.f |
Revision as of 23:21, 8 January 2021
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Moises Romo M.D.
Synonyms and Keywords: encephalitis management, encephalitis workup, encephalitis approach,encephalitis management, encephalitis treatment, encephalitis diagnosis
Overview
Encephalitis refers to the inflammation of the brain. The causes of encephalitis are mostly infectious, beign viruses, bacteria, fungi, or parasites the possible agents. Presentation usually involves headache, fever, confusion, neck stiffness (Kernig and Brudzinski signs), and vomiting. Diagnosis is typically based on clinical presentation and supported by blood tests, medical imaging, and analysis of cerebrospinal fluid. A rapid identification of encephalitis is crucial to reduce sequelae. Management is directed against the affecting agent (antivirals, antibiotics), reducing swelling, and supportive measures.
Causes
Life Threatening Causes
Life-threatening causes include conditions that may result in death or permanent disability within 24 hours if left untreated.
- All causes of encephalitis may be potentially fatal or disabiling if left untreated in 24 hours.; among them:
- Infectious
- Bacterial
- Tuberculosis
- Treponema pallidum
- Mycoplasma
- Viral
- Herpes simplex
- Epstein-Barr virus
- Zoster
- Rabies
- HIV
- Cytomegalovirus
- West Nile virus
- St. Louis encephalitis virus
- Japanese encephalitis virus
- Fungal
- Coccidioidomycosis
- Blastomycosis
- Histoplasmosis
- Cryptococcosis
- Protozoan
- Granulomatous amebic
- Toxoplasma
- Bartonella Henselae
- Bacterial
- Autoimmune
- Encephalitis lethargica
- Limbic encephalitis
- Infectious
Common Causes
Diagnosis
Shown below is an algorithm summarizing the diagnosis of encephalitis according to the International Encephalitis Consortium guidelines:
Patient suspicious for encephalitis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PERFORM: • CSF analysis (at least 20 ml): Opening pressure, WBC count with differential, RBC count, protein, glucose, Gram stain and bacterial culture • Routine blood testing • Blood cultures • HSV-1/2 PCR • VZV PCR • Enterovirus PCR • Cryptococcal antigen and/or India Ink staining • Oligoclonal bands and IgG index • VDRL • HIV serology • Hold acute serum and collect convalescent serum 10–14 d later for paired antibody testing • Neuroimaging (MRI preferred to CT, if available) • Chest imaging (Chest x-ray and/or CT) • EEG | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Evaluate further testing if additional risk factors are present | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Host factors | Geographic factors | Season and exposure | Specific signs and symptoms | laboratory features | Neuroimaging features | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Immunocompromised: • CMV PCR • HHV6/7 PCR • HIV PCR (CSF) • Toxoplasma gondii serology and/or PCR • MTB testing • Fungal testing • WNV testing | Africa: • Malaria (blood smear) • Trypanosomiasias (blood/CSF smear • Serology from serum and CSF) • Dengue testing | Summer/Fall: • Arbovirusd and tick-borne disease testing | Psychotic features or movement disorder: • Anti-NMDAR antibody (serum, CSF) • Rabies testing • Screen for malignancy • Creutzfeld-Jakobs disease | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Asia: • Japanese encephalitis virus testing • Dengue testing • Malaria (blood smear) • Nipah virus testing | Cat exposure (particularly if with seizures, paucicellular CSF): • Bartonella antibody (serum), ophthalmologic evaluation | Prominent limbic symptoms: • Autoimmune limbic encephalitis testing • HHV6/7 PCR (CSF) • Screen for malignancy | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Australia: • Murray Valley encephalitis virus testingd • Kunjin virus testingd • Australian Bat Lyssavirus (ABLV) testing | Tick exposure: • Tick borne disease testing | Rapid decompensation (particularly with animal bite history or prior travel to rabies-endemic areas): • Rabies testing | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Europe: • Tick-borne encephalitis virus (serology) | Animal bite/bat exposure: • Rabies testing | Respiratory symptoms: • Mycoplasma pneumoniae serology and throat PCR (if either positive, then do CSF PCR) • Respiratory virus testing | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Southern Europe: • WNV testing • Toscana virus testing | Swimming or diving in warm freshwater or nasal/sinus irrigation: • Naegleria fowleri (CSF wet mount and PCR) | Acute flaccid paralysis: • Arbovirus testingd • Rabies testing | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Central and South America: • Dengue testingd • Malaria (blood smear) • WNV • Venezuelan equine encephalitis testing | Parkinsonism: • Arbovirus testingd • Toxoplasma serology | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
North America: • Geographically appropriate arboviral testing (eg, WNV, Powassan, LaCrosse, Eastern Equine Encephalitis virusesd, Lyme(serum ELISA and Western blot) | Nonhealing skin lesions: • Balamuthia mandrillaris • Acanthamoeba testing | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Diagnostic Criteria for Encephalitis and Encephalopathy of Presumed Infectious or Autoimmune Etiology according to the International Encephalitis Consortium |
Major Criterion (required): |
Patients presenting to medical attention with altered mental status (defined as decreased or altered level of consciousness, lethargy, or personality change) lasting ≥24 h with no alternative cause identified. |
Minor Criteria (2 required for possible encephalitis; ≥3 required for probable or confirmeda encephalitis): |
Documented fever ≥38° C (100.4°F) within the 72 h before or after presentationb |
Generalized or partial seizures not fully attributable to a preexisting seizure disorderc |
New onset of focal neurologic findings |
CSF WBC count ≥5/cubic mmd |
Abnormality of brain parenchyma on neuroimaging suggestive of encephalitis that is either new from prior studies or appears acute in onset |
Abnormality on electroencephalography that is consistent with encephalitis and not attributable to another cause.f |
Do not modify |
Treatment
Shown below is an algorithm summarizing treatment of encephalitis according to the American Academy of Neurology guidelines: